Cargando…
Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
A positive family history is a strong and consistently reported risk factor for gastric cancer (GC). So far, it has been demonstrated that serum pepsinogens (PGs), and gastrin 17 (G17) are useful for screening individuals at elevated risk to develop atrophic gastritis but they are suboptimal biomark...
Autores principales: | Corona, Giuseppe, Cannizzaro, Renato, Miolo, Gianmaria, Caggiari, Laura, De Zorzi, Mariangela, Repetto, Ombretta, Steffan, Agostino, De Re, Valli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877611/ https://www.ncbi.nlm.nih.gov/pubmed/29518896 http://dx.doi.org/10.3390/ijms19030750 |
Ejemplares similares
-
Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020) -
Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021) -
Family’s History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form
por: Caggiari, Laura, et al.
Publicado: (2020) -
Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018) -
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)